127 related articles for article (PubMed ID: 34743122)
1. Management of Transected Invasive Melanoma: A Single Institution Retrospective Review.
Duncan JR; Beal LL; Daugherty A; Elston C; Contreras C; Phillips CB; Huang C
Dermatol Surg; 2022 Jan; 48(1):47-50. PubMed ID: 34743122
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of patients with transected melanomas.
Martires KJ; Nandi T; Honda K; Cooper KD; Bordeaux JS
Dermatol Surg; 2013 Apr; 39(4):605-15. PubMed ID: 23379583
[TBL] [Abstract][Full Text] [Related]
3. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management.
Saco M; Thigpen J
J Drugs Dermatol; 2014 May; 13(5):531-6. PubMed ID: 24809875
[TBL] [Abstract][Full Text] [Related]
4. Internal Pathology Review of Invasive Melanoma: An Academic Institution Experience.
Isom C; Hooks M; Kauffmann RM
J Surg Res; 2020 Jun; 250():97-101. PubMed ID: 32044512
[TBL] [Abstract][Full Text] [Related]
5. Frequency of and risk factors for tumor upstaging after wide local excision of primary cutaneous melanoma.
Etzkorn JR; Sharkey JM; Grunyk JW; Shin TM; Sobanko JF; Miller CJ
J Am Acad Dermatol; 2017 Aug; 77(2):341-348. PubMed ID: 28601390
[TBL] [Abstract][Full Text] [Related]
6. Upstaging of melanoma in situ and lentigo maligna treated with Mohs micrographic surgery rarely results in additional surgical management.
Levoska MA; Schmults CD; Waldman AH
Arch Dermatol Res; 2020 Dec; 312(10):753-756. PubMed ID: 32002653
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of partial biopsies in the management of cutaneous melanoma.
Doolan BJ; Robinson AJ; Wolfe R; Kelly JW; McLean C; McCormack C; Henderson MA; Pan Y
Australas J Dermatol; 2019 Aug; 60(3):209-213. PubMed ID: 30773625
[TBL] [Abstract][Full Text] [Related]
8. The increasing use of shave biopsy for diagnosing invasive melanoma in Australia.
de Menezes SL; Kelly JW; Wolfe R; Farrugia H; Mar VJ
Med J Aust; 2019 Sep; 211(5):213-218. PubMed ID: 31328802
[TBL] [Abstract][Full Text] [Related]
9. Upstaging From Melanoma in Situ to Invasive Melanoma on the Head and Neck After Complete Surgical Resection.
Gardner KH; Hill DE; Wright AC; Brewer JD; Arpey CJ; Otley CC; Roenigk RK; Baum CL
Dermatol Surg; 2015 Oct; 41(10):1122-5. PubMed ID: 26356849
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of pigmented lesions managed by shave excision with no deep margin transection of melanomas.
Shao E; Blake T; Po-Chao F; Pool L; Carew B; Yong-Gee S; Wheller L; De'Ambrosis B; Muir J
Australas J Dermatol; 2020 Aug; 61(3):269-272. PubMed ID: 32419172
[TBL] [Abstract][Full Text] [Related]
11. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
12. The rate of melanoma transection with various biopsy techniques and the influence of tumor transection on patient survival.
Mir M; Chan CS; Khan F; Krishnan B; Orengo I; Rosen T
J Am Acad Dermatol; 2013 Mar; 68(3):452-8. PubMed ID: 22967665
[TBL] [Abstract][Full Text] [Related]
13. Clinical Impact and Accuracy of Shave Biopsy for Initial Diagnosis of Cutaneous Melanoma.
Jones S; Henry V; Strong E; Sheriff SA; Wanat K; Kasprzak J; Clark M; Shukla M; Zenga J; Stadler M; Dzwierzynski W; Harker-Murray A; Young K; Kothari AN; Clarke CN
J Surg Res; 2023 Jun; 286():35-40. PubMed ID: 36739830
[TBL] [Abstract][Full Text] [Related]
14. The impact of biopsy technique on upstaging, residual disease, and outcome in cutaneous melanoma.
Egnatios GL; Dueck AC; Macdonald JB; Laman SD; Warschaw KE; DiCaudo DJ; Nemeth SA; Sekulic A; Gray RJ; Wasif N; Pockaj BA
Am J Surg; 2011 Dec; 202(6):771-7; discussion 777-8. PubMed ID: 22000117
[TBL] [Abstract][Full Text] [Related]
15. Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy.
Bolshinsky V; Lin MJ; Serpell J; Leung M; Wolfe R; McLean C; Kelly JW
J Am Acad Dermatol; 2016 Jan; 74(1):102-7. PubMed ID: 26601566
[TBL] [Abstract][Full Text] [Related]
16. Residual melanoma in wide local excision specimens after 'complete' excision of primary cutaneous in situ and invasive melanomas.
Jackett LA; Satgunaseelan L; Roper E; Lo SN; Thompson JF; Scolyer RA
Pathology; 2022 Feb; 54(1):71-78. PubMed ID: 34392983
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated With Upstaging of Melanoma Thickness on Final Excision.
Gazivoda VP; Koshenkov VP; Kangas-Dick AW; Greenbaum A; Davis C; Smith FO; Hilden PD; Berger AC
J Surg Res; 2023 Sep; 289():253-260. PubMed ID: 37150080
[TBL] [Abstract][Full Text] [Related]
18. Microstaging accuracy after subtotal incisional biopsy of cutaneous melanoma.
Karimipour DJ; Schwartz JL; Wang TS; Bichakjian CK; Orringer JS; King AL; Huang CC; Johnson TM
J Am Acad Dermatol; 2005 May; 52(5):798-802. PubMed ID: 15858469
[TBL] [Abstract][Full Text] [Related]
19. Single-center, single-operator, retrospective analysis of base transection rates in shave procedures for melanoma diagnosis.
Pitney T; Muir DJ
J Am Acad Dermatol; 2021 Mar; 84(3):861-862. PubMed ID: 33616070
[No Abstract] [Full Text] [Related]
20. Risk factors associated with tumor upstaging in melanomas treated with Mohs micrographic surgery with melanocytic immunohistochemistry.
Trischman T; Bangalore Kumar A; Asamoah EM; Todd A; Vidal NY; Demer AM
JAAD Int; 2024 Sep; 16():3-8. PubMed ID: 38756446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
